flurbiprofen has been researched along with Recrudescence in 6 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-eight coronary care units (CCUs) in France participated in this double-blind, placebo-controlled, multicentre study to assess the efficacy of flurbiprofen, a non-steroidal anti-inflammatory agent (NSAID) with potent anti-platelet activity (PAA), in the prevention and recurrence of myocardial infarction (MI) and reocclusion of the infarct-related artery (IRA) in patients successfully treated for acute MI by thrombolysis and/or coronary angioplasty within 6 h of onset of symptoms." | 9.07 | Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. The Flurbiprofen French Trial. ( Brochier, ML, 1993) |
| "A multicentre controlled trial was conducted on 383 patients to compare the effectiveness of flurbiprofen (100 mg/day) and an ergot derivative in preventing cerebral infarction." | 9.05 | [Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative]. ( Dehen, H; Dordain, G; Doyon, F, 1984) |
| "Thirty-eight coronary care units (CCUs) in France participated in this double-blind, placebo-controlled, multicentre study to assess the efficacy of flurbiprofen, a non-steroidal anti-inflammatory agent (NSAID) with potent anti-platelet activity (PAA), in the prevention and recurrence of myocardial infarction (MI) and reocclusion of the infarct-related artery (IRA) in patients successfully treated for acute MI by thrombolysis and/or coronary angioplasty within 6 h of onset of symptoms." | 5.07 | Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. The Flurbiprofen French Trial. ( Brochier, ML, 1993) |
| "A multicentre controlled trial was conducted on 383 patients to compare the effectiveness of flurbiprofen (100 mg/day) and an ergot derivative in preventing cerebral infarction." | 5.05 | [Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative]. ( Dehen, H; Dordain, G; Doyon, F, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balta, I | 1 |
| Simsek, H | 1 |
| Simsek, GG | 1 |
| Sendur, MA | 1 |
| Aksoy, S | 1 |
| Ozdemir, NY | 1 |
| Yaman, S | 1 |
| Zengin, N | 1 |
| Rampton, DS | 1 |
| Sladen, GE | 1 |
| Dehen, H | 1 |
| Dordain, G | 1 |
| Doyon, F | 1 |
| Healy, CM | 1 |
| Thornhill, MH | 1 |
| Brochier, ML | 1 |
2 trials available for flurbiprofen and Recrudescence
| Article | Year |
|---|---|
[Secondary prevention of cerebral infarction caused by atherosclerosis. 3-year comparison of flurbiprofen and an ergot derivative].
Topics: Arteriosclerosis; Cerebral Infarction; Clinical Trials as Topic; Ergot Alkaloids; Female; Flurbiprof | 1984 |
Evaluation of flurbiprofen for prevention of reinfarction and reocclusion after successful thrombolysis or angioplasty in acute myocardial infarction. The Flurbiprofen French Trial.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Double-Blind Method; Female; Flurbiprofen; Hemorrhage; | 1993 |
4 other studies available for flurbiprofen and Recrudescence
| Article | Year |
|---|---|
Flurbiprofen-induced generalized bullous fixed drug eruption.
Topics: Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Blister; Combined Modality Therapy | 2014 |
Flurbiprofen-induced unilateral eyelid angioedema.
Topics: Administration, Oral; Adult; Analgesics; Angioedema; Anti-Allergic Agents; Drug Hypersensitivity; Ey | 2014 |
Relapse of ulcerative proctocolitis during treatment with non-steroidal anti-inflammatory drugs.
Topics: Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Female; Flurbiprofen; Humans; Ibuprofen; Indom | 1981 |
An association between recurrent oro-genital ulceration and non-steroidal anti-inflammatory drugs.
Topics: Diclofenac; Drug Hypersensitivity; Female; Flurbiprofen; Genital Diseases, Female; Humans; Middle Ag | 1995 |